SUMMARY. In December 2005, the four major Swiss zoos carried out the vaccination of selected zoo birds with the adjuvant inactivated vaccine H5N2 Nobilis influenza. Pre-and post-vaccination antibody titers were determined either by hemagglutination inhibition (HI) test (non-Galliformes) or by enzyme linked immunosorbent assay (ELISA) (Galliformes) at Week 0, 5, 10, [35][36][70][71] and 182 respectively) to determine the humoral immune response to H5 antigen. After the first vaccination, the overall geometric mean titer of non-Galliformes was 65 (n 5 142), which increased to 187 (n 5 139) after booster vaccination and dropped to 74 (n 5 65) six months after first vaccination. For the Galliformes group, the mean titers were found to be 2.09 at Week 5 (n 5 119), 3.24 at Week 10 (n 5 113), and 1.20 at Week 26 (n 5 39). Within the non-Galliformes, significant differences in geometric mean titers were found among different species representatives. In general, the flamingos (Phoenicopteriformes) showed a strong response to vaccination, reaching a geometric mean titer of 659 at Week 10, while the Sphenisciformes did not show high antibody titers even after booster vaccination, reaching a maximum geometric mean titer of only 65. Based on the antibody titer profiles of all investigated species, we recommend at least annual revaccination for the species that we investigated.
Influenza viruses are pleomorphic, enveloped, single-stranded RNA viruses of the family Orthomyxoviridae. They are classified as types A, B, and C, based on the antigenic differences between their nucleoproteins and matrixproteins (4). The influenza B and C viruses are not divided into subtypes, in contrast to influenza A viruses, which are further classified based on the divergence between their two major antigenic determinants, hemagglutinin (HA) and neuraminidase (NA) (12, 19) . To date, 16 HA and 9 NA subtypes of influenza A viruses have been identified (8) . Viruses are additionally characterized by their hosts, geographic origin (place of isolation), strain number, year of isolation, and finally the subtype; all enclosed in parentheses (4,10). Influenza A viruses are found in a large variety of mammals and birds (8) . Aquatic birds such as Anseriformes (waterfowl) and Charadriiformes (shorebirds) represent the natural reservoir of the influenza A viruses (17) and have been demonstrated to be susceptible for all of the 16 HA and 9 NA subtypes (12, 13) .
Influenza viruses of the HA subtype H5 and H7 are the etiologic agents of a highly contagious, and frequently serious, acute respiratory and gastrointestinal disease in aviculture, causing considerable financial losses in affected areas as well as in neighboring regions (7) .
Highly pathogenic and notifiable low-pathogenic avian influenza viruses pose a special peril to zoos, considering that the birds they keep are often of great value from the point of view of conservation. The disease poses a twofold threat, by either 1) the epidemic itself, or by 2) the control measures adopted when a notifiable avian influenza virus is identified in the population, measures which often include culling-or stamping-out of birds within the affected areas. Because treatment of avian influenza in birds is not considered an option, prevention of the disease by vaccination has been recommended (2, 21) .
Commercial vaccines are available for poultry (6) , and it has been shown that such vaccines also protect ducks. It was demonstrated that vaccinated birds do not develop clinical signs when infected C with the challenge viruses, and that vaccinated ducks had reduced shedding of the challenge virus (3, 20, 22) . Vaccination has also been discussed as an option to protect rare species in zoological gardens (5) . Vaccination studies of multispecies bird collections in zoos have been carried out with H7N2 and H5N2 vaccines in Dutch zoos (16, 17) , with H5N2 vaccine at the Singapore zoo (14) , and with H5N9 vaccine in Danish zoos (1) . From these reports, it could be concluded that vaccination is safe, and that the vaccine elicits a humoral immune response. However, there are also reports in these studies describing differences in antibody mediated immune responses among avian species. Furthermore, antibody titer profiles over an extended period of several months were not investigated in nondomestic birds. In Galliformes, annual boostering is recommended (5), but the interval for other species is not known.
Therefore, the purposes of this study were to examine the speciesdependent humoral immune responses among zoological avian collections following vaccination with a commercial H5N2 avian influenza vaccine, and to determine the decrease of antibody titers, after a period of six months, in regard to the estimation of the likely interval of revaccination in different species.
MATERIALS AND METHODS
Animals. In the present study, 365 birds were vaccinated in the four Swiss zoos of Basel, Berne, Goldau, and Zurich (Table 1 ). The selection of animals reflects aspects such as susceptibility to avian influenza, conservation status, housing conditions, and size of population. All animals involved in the study were clinically healthy. All birds were continuously monitored by the attending veterinarian and by the keepers for adverse reaction to vaccination. Experimental procedures were evaluated and approved by the cantonal Animal Care and Use Committee and licensed under number 192/2005.
Vaccination. Birds were vaccinated twice, with an interval of five weeks (on Day 0-1 and Day 35-36), with an inactivated H5N2 vaccine, (strain A/Chicken/Mexico/232/95/CPA [H5N2]) with liquid paraffin adjuvant (Intervet, Boxmeer, Netherlands). This vaccine strain was chosen in regard to the avian influenza virus strain circulating across Europe in 2005 and with respect to ''differentiating infected from vaccinated animals''-the DIVA concept. Doses were 0.25 ml for bird species with a body weight below 1.5 kg; 0.5 ml for species with a body weight between 1.5 kg and 20 kg; and 1.0 ml for species with a body weight $ 20 kg. The vaccine was injected subcutaneously in the dorsal cervical region or in the femoral region, and intramuscularly in the pectoral or the femoral region. Pelicans (Pelecanus crispius) were injected intramuscularly in the femoral region due to the large extension of their subcutaneous air sacs (18). Other species, such as Recurvirostra avosetta (pied avocet) and Athene noctua (little owl), were injected intramuscularly due to their small size.
Blood collection protocols. Blood sampling was performed on the day of first vaccination (Day 0-1) and at Week 5 (Day 35-36; booster vaccination), Week 10 (Day 70-71), and Week 26 (Day 182). Sampling sites were the vena brachialis, v. metatarsalis medialis, or the v. jugularis dextra, and a minimum of 1 ml blood was collected from each sampled bird. The blood was collected in Eppendorf (microfuge) tubes (2.5 ml), separated at 2400 3 g for 5-10 minutes, 1-8 hours after collection, and serum was stored at 220 C until analysis.
Inhibition of hemagglutination. All non-Galliformes sera were analyzed for the presence of anti-H5 antibodies using the HI test following standard procedures (11), and using chicken red blood cells (15). Back titration of antigen (Antigen lot. no. 822, strain A/chicken/ Mexico/232/95/CPA [H5N2]), (Intervet) was included in all tests to quantify the number of HAUs contained in 25 ml antigen.
Hemagglutination inhibition titers were regarded as positive at a serum dilution of 1:16 (in other words, a geometric mean titer (GMT) $ 16 represents positive titers) or more against 4 HAU of antigen (15). Geometric mean titer and confidence intervals (CI) of 95% were subsequently calculated per avian order (Anseriformes, Ciconiiformes, Coraciiformes, Falconiformes, Passeriformes, Pelicaniformes, Phoenicopteriformes, Psittaciformes, Sphenisciformes, and Strigiformes), with the exception of orders with a small number of individuals (,10).
ELISA. All sera from Galliformes collected during the 26-week period were analyzed by the IDEXX FlockChek AI ELISA (IDEXX GmbH, Ludwigsburg, Germany), an assay designed to measure the relative level of antibody to AI in chicken and turkey serum. The main reasons for utilizing the IDEXX ELISA to test Galliformes were that this test is 1) rapid and reliable; 2) a good option to the HI test for Galliformes; and 3) sensitive not only to H5 but also to antibodies against 13 other HAs. This analysis was performed according to the manufacturer's instructions. The positive control was standardized and represented significant antibody levels to AI in chicken serum. The relative level of antibody in the unknown was determined by calculating the ratio of the sample (S) to the positive (P) control (S/P). All S/P ratios $ 0.5 were considered positive. Mean titers and CI of 95% were subsequently calculated per species (rock partridge, Australian brushturkey, brahma chicken, barth chicken, cochin chicken, orpington chicken, silky chicken, Himalayan monal, turkey, common peafowl, capercaille, and satyr tragopan), with the exception of species with small number of individuals (n , 10).
Correlation between HI test and ELISA. Evaluations and the comparison of the common HI and the IDEXX FlockChek AI ELISA test were performed by IDEXX Laboratories as well as by laboratories in Mexico and China. These examinations revealed a high correlation (between 96.3% and 100%) between the two tests (9).
Statistical methods. Pre-vaccination and post-vaccination antibody titers were subjected to statistical analysis to evaluate significance in differences observed among and within orders, species, and sampling dates. The Friedman ANOVA and Kendall coefficient of concordance were used to assess whether samples from at least one sampling date would differ from the other three. To allow individual comparison regarding observed differences in antibody titer, both within the orders and at different points in time, the Wilcoxon matched pairs test was performed. To assess whether there would be significant differences among orders within the same sampling week, antibody titers were analyzed, by ranks, with a Kruskal-Wallis ANOVA and by MannWhitney U-test; values of P , 0.05 were considered significant.
RESULTS
A total of 365 birds, belonging to 14 orders and representing 56 species, were vaccinated ( Table 1 ). The vaccine was well tolerated by all birds, and no clinically significant reaction was noted at the injection site. In one peacock (Pavus cristatus), euthanatized ten weeks after first vaccination for reasons unrelated to the study, a 2 cm 3 1.5 cm subcutaneous inflammation at the injection site was noted. Three casualties occurred, one of which was a common kestrel (Falco tinnunculus) that escaped. Two birds died during the sampling procedure; a cattle egret (Ardeola ibis) due to hemorrhages and a satyr tragopan (Tragopan satyra) due to stress. During the 26-week study period, a total of 872 samples were taken from these birds.
For the serological survey, 256, 261, 252, and 103 samples were taken at first (Week 0 or Day 0-1) and second (Week 5 or Day 35-36) vaccination and at Week 10 (Day 70-71) and 26 (Day 182). The last sampling period took place in June, when many of the birds involved in the study were brooding. To avoid the risk of incubation damage, the zoos decided to spare the birds additional stress, resulting in a significant drop in the number of study birds.
Statistical analysis of pre-vaccination and post-vaccination antibody titers revealed significant differences among and within orders. Table 2 summarizes the serum antibody titers of the different non-Galliformes orders. In total, 484 sera from 169 vaccinated non- Table 1 . Number, species, and GMT or S/P ratio of birds vaccinated with an inactivated H5N2 vaccine at Weeks 0, 5, 10, and 26. Galliformes were collected and analyzed by HI test. All these birds had pre-vaccination titers # 8, with the exception of four animals: a barheaded goose (Anser indicus); a blue-and-yellow macaw (Ara ararauna); a kookaburra (Dacelo gigas); and a Falkland flightless steamer duck (Tachyeres brachypterus), with titers of 16, 16, 32, and 32, respectively. Under the conditions of this investigation, all orders other than Galliformes showed seroconversion after the first vaccination, reaching GMT titers between 32.0 and 658.79; and booster vaccination led to significantly enhanced antibody production in all these birds, with the exception of the flamingos (Phoenicopteriformes) and the penguins (Sphenisciformes). Generally, significant differences in humoral immune responses between different nonGalliformes orders were observed. Among all analyzed orders, the Phoenicopteriformes had the highest titers, with GMTs of 658.7 at week 5 and 696.7 at Week 10. Sphenisciformes had the lowest titers among all non-Galliformes, with GMTs of 65.4 five weeks after booster vaccination. Other orders with low titers, when compared with other groups, were pelicans (Pelicaniformes), parrots (Psittaciformes), and owls (Strigiformes), with GMTs of 90.5, 80.6, and 65.1, respectively, after booster vaccination. A general decrease in serum antibody was observed in all birds, ranging from 21% in Psittaciformes (GMT fell from 80.6 to 64) to 85% in Sphenisciformes (GMT fell from 65.4 to 9.7). Furthermore, the penguins were the only group returning to negative titers after the 26-week study period. ( Table 3 ). The IDEXX ELISA test is validated for testing chicken and turkey antibodies against 20 different avian influenza virus strains. As shown in Table 1 Three birds of 119 (total sampled Galliformes at Week 0) had positive pre-vaccination titers: one barth chicken, one brahma chicken, and one silky chicken, with S/P ratios of 0.61, 0.52, and 1.19, respectively. After first vaccination, 80% of the Galliformes (95 of 119 birds) showed seroconversion. Ten weeks after the first vaccination (which was five weeks after booster vaccination), the number of birds with S/P ratio $ 0.5 rose to 96% (108 of 113 birds sampled at Week 10). Twenty-six weeks after first vaccination, 39 samples from Galliformes revealed an overall mean S/P ratio of 1.21 (Table 3) , with 79% of the birds having titers $ 0.5. Peacocks (Pavus cristatus) showed particularly strong response to H5N2 inoculation, reaching a mean S/P ratio of 4.84 five weeks after the first vaccination, and of 5.71 after ten weeks. The capercailles (Tetrao urogallus major) had the lowest titers, with an S/P ratio of only 0.56 at Week 10. All species sampled at Week 26 showed a decrease of antibody titers, but mean S/P ratios were still .0.5. Six months after the first vaccination, the peacocks still had the highest titers among all Galliformes, with an S/P ratio of 3.41.
DISCUSSION
The present study measured the humoral immune response to a commercial adjuvanted inactivated vaccine against H5N2 avian influenza in a multitude of bird species. Currently, there is no avian influenza vaccine labelled and licensed for species other than chickens. Therefore, the data presented here do not allow any definite conclusion regarding protection in the case of an outbreak of highly pathogenic avian influenza (HPAI).
The vaccine is safe, based on our observations. No adverse reactions were observed following vaccination in any of the birds, with the exception of minor swelling at the injection site in a peacock. This observation is in agreement with the studies in multispecies environments of Oh et al. (14) using the same vaccine; of Philippa et al. (16, 17) using an H7N1 and an H5N2 vaccine; and of Bertelsen et al. (1) using an H5N9 vaccine. In our study, the vaccine was applied subcutaneously or intramuscularly. The IM inoculation route was chosen in very small birds, due to easier handling, as an option to the subcutaneous injection; and chosen in pelicans to avoid injection of the vaccine into their subcutaneous airsacs. Statistical comparison between the two administration modalities, with regard to humoral immune response, was not possible. The dosages were chosen on the basis of prior investigations on the use of an H7N1 vaccine, performed by Philippa et al., which described an inverse correlation between body weight and antibody response in birds $1.5 kg (17).
No positive pre-vaccination titers were found with the exception of three birds out of 119 sampled Galliformes and four birds out of 137 sampled non-Galliformes. Therefore, an exposure of a few birds to low pathogenic avian influenza, without clinical consequences, is plausible.
Five weeks after the first vaccination, 78% of the Galliformes and 98% of the non-Galliformes birds showed seroconversion. These two values cannot be directly compared due to the fact that two different tests were used. At week five, the Phoenicopteriformes (flamingos) had the highest antibody titers and showed very strong response to first inoculation. Seroconversion rates after the second vaccine inoculation were 96% for the Galliformes and 100% for the non-Galliformes, leading to the conclusion that a second vaccination within five weeks after the first vaccination generally serves its purpose to significantly increase humoral immune response. In the studies published by Oh et al. (14) and by Bertelsen et al.
(1), a seroconversion (HI titer $ 16) rate of 84% was denoted after booster vaccination, which is lower than our result. By contrast, Philippa et al. (16, 17 ) chose a different threshold for significant seroconversion (HI titers $ 40) and indicated a seroconversion of 80% and 81%. If we chose the same seroconversion threshold as Philippa et al. (16, 17) , then 85% of our birds showed titers $40 at Week 10. This shows that our results are comparable to those assessed by Philippa et al. Exceptions to the positive effect of booster Table 3 . ELISA: S/P ratios of Galliformes vaccinated with an inactivated H5N2 vaccine at weeks 0, 5, 10, and 26. CI of 95% was calculated for species with n $ 10.
A S/P ratios within a column with different lowercase letters (a, b, c, d, e) differ significantly. showed only a slight increase in humoral production induced through booster vaccination, a single vaccination may be adequate. This might be noteworthy, since the capture represents an important stress to the entire flock. Oh et al. (14) described that Pelicaniformes failed to respond to IM vaccination with 0.5 ml/kg body weight vaccine (5.5 ml/ individual, which is elevenfold the dose administered in our study). Our pelicans were injected with a 0.5-ml dose into the thigh muscles and responded to vaccination with GMTs of 76.1 at Week 5 and 90.5 at Week 10. Due to their large superficial air sacs, IM injection into the femoral region might be the preferable option, even though their titers were significantly lower compared to some other bird species. Oh et al. (14) did not find a titer in owls after a triple injection of a dose of 0.5 ml/kg bodyweight. In contrast, the Strigiformes vaccinated in our study showed reaction to vaccination with GMT of 128 (100% $ 16) after booster vaccination, indicating that the vaccine did induce antibody formation in this avian order. The studies by Philippa et al. (16) and by Bertelsen et al.
(1) found GMTs of 89 (50% $ 40) and 81 (100% $ 32), respectively, corroborating our results for the owls. The differences in responsiveness between the various avian orders may be caused first of all by the species and order differences, secondly by a potentially inappropriate vaccine, thirdly by the potentially not sufficient dosage, and fourth, by the time interval between first and booster vaccinations.
The main aim of this study was the evaluation of humoral immune response over a period of six months. Generally, when GMTs of Week 10 and Week 26 were compared, a decrease of the serum antibodies to H5 could be observed in all involved bird species. Titer decreases were ranging between 21% (from 80.6 to 64) and 85% (from 65.4 to 9.7), and therefore were considerable, but these decreases did not lead to negative GMT or S/P ratios in orders other than Sphenisciformes. The fact that, 26 weeks after first vaccination, the GMT of Humboldt penguins' serum was negative (,16) raises the questions if annual revaccination is enough to ensure protection for this species over a long period of time and if the vaccine and the dosage used were adequate. Instead, it seems that Psittaciformes tend to have a slower titer decrease than all other orders. Further studies are warranted to test for other vaccines, dosages, booster, and re-vaccination intervals.
From the 119 vaccinated Galliformes, all but the capercailles showed a humoral reaction to first vaccination, reaching positive titers. Within the Galliformes, the peacocks were noted for their strong responses to first vaccination, comparable to the flamingos within the non-Galliformes. But in contrast to them, the peacocks increased their antibody production significantly after booster vaccination ( Table 3) .
As is apparent in Table 3 , it can be seen that the rock partridge (Alectoris graeca) and the Himalayan monal (Lophoporus inpejanus), in contrast to all other species, showed no relevant reaction to booster vaccination. Nevertheless, it has to be noted that the number of individuals of the two afore-mentioned species is small and therefore, the significance of measured titers is questionable. From Week 10-26, the species appertaining to the order of Galliformes showed a titer decrease (from 5.71-3.42) ranging between 40% for the peacocks and (from 3.32-0.49) 85% for the brahma chickens. These findings show that differences in humoral responsiveness and constancy of antibody titers have to be expected among birds belonging to different orders, as well as among closely related birds of the same order.
In conclusion, it could be shown that vaccination in a multispecies collection is well tolerated and will result in significant humoral immune response. However, no conclusions regarding protectivity of the titers of non-Galliformes can be made at this point.
Approximately six months after the initial vaccination, titers were decreased, leading to the conclusion that annual revaccination appears warranted in zoo birds, as it is in chickens in high-risk areas.
In certain species such as penguins, even shorter intervals may be necessary. However, further work on the susceptibility to AI in species other than Galliformes and Anseriformes is needed to make conclusive recommendations. Even so, vaccination may be a useful strategy to save exotic and valuable birds from confinement and preemptive culling in view of a potential outbreak of AI.
